OTLK
Outlook Therapeutics Inc
Price:  
1.75 
USD
Volume:  
320,919
United States | Biotechnology

OTLK Net Margin

As of 2025-05-19, the Net Margin of Outlook Therapeutics Inc (OTLK) is -423.8%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

OTLK Net Margin - Historical Value
DateValue
2023-09-30 -423.8%
2022-09-30 -
2021-09-30 -
2020-09-30 -
2019-09-30 -423.8%
2018-09-30 -974.6%
2017-09-30 -1019.3%
2016-09-30 -1788.9%
2015-09-30 -908.1%
2014-09-30 -151.7%
OTLK Net Margin - Peers Comparison